SCHEMBL27409362

SCHEMBL27409362

O=C(Nc1csc2c(Cl)ncnc12)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.60
ADORA3 P0DMS8 2/20 0.52
ADORA2A P29274 1/20 0.52
ADORA1 P30542 1/20 0.52
GRM4 Q14833 1/20 0.43
KDR P35968 1/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
KCNMA1 Q12791 1/20 0.42
KCNQ3 O43525 1/20 0.42
KCNQ2 O43526 1/20 0.42
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KDM4A O75164 1/20 0.40
KDM4B O94953 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27244267 0.79 PKM (0.39) PDPK1MAPTKDM4EKMT2AMAPK1
SCHEMBL27409356 0.76 FGFR1 (0.41) PDPK1NPC1RAB9AMAPTKDM4E
SCHEMBL27409347 0.76 FGFR1 (0.40) PDPK1GRM4NPC1RAB9AMAPT
SCHEMBL783675 0.74 ADORA3 (0.57) ADORA3ADORA2AADORA1NPC1RAB9A
SCHEMBL27409375 0.73 AXL (0.35) PDPK1
SCHEMBL27409171 0.73 PDPK1 (0.47) PDPK1KDRHDAC1HDAC8HDAC6
SCHEMBL2235253 0.69 LMNA (0.37) ADORA3ADORA2AADORA1MAPTLMNA
SCHEMBL1761004 0.68 ADORA3 (1.00) ADORA3ADORA2AADORA1KDRNPC1
SCHEMBL3790102 0.68 NPC1 (0.68) NPC1RAB9AKCNMA1MAPTMEN1
SCHEMBL3096372 0.68 RAB9A (0.79) KDRNPC1RAB9AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS ENPP1, ENPP3, ENTPD5 PDPK1 127/4885ADORA3 946/4885ADORA2A 828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.